News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer's disease in 2023.

Mol Neurodegener · 2023 · PMC10518943 · PMID 37749530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A novel cognitive endpoint developed by the investigators (known as the iADRS for Integrated AD Rating Scale) also showed a highly significant benefit [ 6 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.